Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases

Diseases caused by chronic inflammation (e.g., arthritis, multiple sclerosis and diabetic ulcers) are multicausal, thus making treatment difficult and inefficient. Due to the age-associated nature of most of these disorders and the demographic transition towards an overall older population, efficient therapeutic intervention strategies will need to be developed in the near future. Over the past decades, elimination of activated macrophages using CD64-targeting immunotoxins has proven to be a promising way of resolving inflammation in animal models. More recent data have shown that the M1-polarized population of activated macrophages in particular is critically involved in the chronic phase. We recapitulate the latest progress in the development of IT. These have advanced from full-length antibodies, chemically coupled to bacterial toxins, into single chain variants of antibodies, genetically fused with fully human enzymes. These improvements have increased the range of possible target diseases, which now include chronic inflammatory diseases. At present there are no therapeutic strategies focusing on macrophages to treat chronic disorders. In this review, we focus on the role of different polarized macrophages and the potential of CD64-based IT to intervene in the process of chronic inflammation.

• Publication year

  2012

• Venue

  Toxins

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/toxins4090676PMID 23105975PMCID 3475223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of MMX® Mesalamine on Improvement and Maintenance of Health-Related Quality of Life in Patients with Ulcerative Colitis

  2013cited by this paper
• Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes

  2012cited by this paper
• Therapeutic targets and recent advances in protein immunotoxins.

  2012cited by this paper
• An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series.

  2012cited by this paper
• Evaluating Risks, Costs, and Benefits of New and Emerging Therapies to Optimize Outcomes in Multiple Sclerosis

  2012cited by this paper
• Reduction of activated macrophages after ischaemia-reperfusion injury diminishes oxidative stress and ameliorates renal damage.

  2012cited by this paper
• Macrophage plasticity and polarization: in vivo veritas.

  2012cited by this paper
• Summary of AHRQ’s Comparative Effectiveness Review of Drug Therapy for Rheumatoid Arthritis (RA) in Adults – An Update

  2012cited by this paper
• Macrophage subpopulations in systemic lupus erythematosus.

  2012cited by this paper
• Cytosolic DNA sensors regulating type I interferon induction.

  2011cited by this paper
• Heme Induces Heme Oxygenase 1 via Nrf2: Role in the Homeostatic Macrophage Response to Intraplaque Hemorrhage

  2011cited by this paper
• Macrophages and liposomes in inflammatory disease: friends or foes?

  2011cited by this paper
• An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice.

  2011cited by this paper
• CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages

  2010cited by this paper
• Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.

  2010influential reference
• Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2

  2010cited by this paper
• Immunopathology and Infectious Diseases Suppression of PLC 2 by Endotoxin Plays a Role in the Adenosine A 2 A Receptor-Mediated Switch of Macrophages from an Inflammatory to an Angiogenic Phenotype

  2010cited by this paper
• Alternative activation of macrophages: mechanism and functions.

  2010cited by this paper
• Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

  2010cited by this paper
• Investigation of a plasmid containing a novel immunotoxin VEGF165‐PE38 gene for antiangiogenic therapy in a malignant glioma model

  2010cited by this paper
• Anti‐cancer activity of anti‐p185HER‐2 ricin A chain immunotoxin on gastric cancer cells

  2010cited by this paper
• Recombinant, ETA′‐based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice

  2010cited by this paper
• Alternative activation of macrophages: an immunologic functional perspective.

  2009cited by this paper
• Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.

  2009cited by this paper
• Improved immunotoxins with novel functional elements.

  2009cited by this paper
• Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.

  2009cited by this paper
• Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies.

  2009cited by this paper
• Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy

  2009cited by this paper
• Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy.

  2009cited by this paper
• Targeted Restoration of Down-regulated DAPK2 Tumor Suppressor Activity Induces Apoptosis in Hodgkin Lymphoma Cells

  2009cited by this paper
• A Neutralizing Antibody to the A Chain of Abrin Inhibits Abrin Toxicity both In Vitro and In Vivo

  2008cited by this paper
• Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes

  2008cited by this paper
• Cytokine signaling modules in inflammatory responses.

  2008cited by this paper
• Small Cleavable Adapters Enhance the Specific Cytotoxicity of a Humanized Immunotoxin Directed Against CD64-positive Cells

  2008cited by this paper
• Macrophage activation and polarization.

  2008cited by this paper
• The phagocytes: neutrophils and monocytes.

  2008cited by this paper
• Exploring the full spectrum of macrophage activation

  2008influential reference
• Obesity induces a phenotypic switch in adipose tissue macrophage polarization.

  2007cited by this paper
• The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair.

  2007cited by this paper
• Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.

  2007cited by this paper
• Inflammation in wound repair: molecular and cellular mechanisms.

  2007cited by this paper
• Altered macrophage differentiation and immune dysfunction in tumor development.

  2007cited by this paper
• Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES

  2006cited by this paper
• CD64-Directed Immunotoxin Inhibits Arthritis in a Novel CD64 Transgenic Rat Model1

  2006cited by this paper
• Clearance of apoptotic and necrotic cells and its immunological consequences

  2006cited by this paper
• Lymphatic endothelium‐specific hyaluronan receptor LYVE‐1 is expressed by stabilin‐1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis

  2006cited by this paper
• Biochemical and functional characterization of three activated macrophage populations

  2006cited by this paper
• Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells

  2006cited by this paper
• Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.

  2006cited by this paper
• Monocyte and macrophage heterogeneity

  2005cited by this paper
• Macrophages play a dual role during pulmonary tuberculosis in mice.

  2005cited by this paper
• Immunotoxins and cancer therapy.

  2005cited by this paper
• The Innate Immune System Is Activated by Stimulation of Vaginal Epithelial Cells with Staphylococcus aureus and Toxic Shock Syndrome Toxin 1

  2005cited by this paper
• Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

  2005cited by this paper
• Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent

  2004cited by this paper
• UvA-DARE ( Digital Academic Repository ) Macrophages play a dual role during pulmonary tuberculosis in mice

  2004cited by this paper
• Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

  2004cited by this paper
• The chemokine system in diverse forms of macrophage activation and polarization.

  2004influential reference
• Development and Pharmacokinetics and Pharmacodynamics of Pegylated Interferon Alfa-2a (40 kD)

  2004cited by this paper
• Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling.

  2004cited by this paper
• Effects of Tumor Necrosis Factor-α (TNFα) in Epidermal Keratinocytes Revealed Using Global Transcriptional Profiling*

  2004cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• Pegaspargase: a review of clinical studies.

  2003cited by this paper
• Fc receptor biology.

  2003cited by this paper
• Regulation of chemokine expression by antiinflammatory cytokines

  2002cited by this paper
• Depletion of CCR5-Expressing Cells with Bispecific Antibodies and Chemokine Toxins: A New Strategy in the Treatment of Chronic Inflammatory Diseases and HIV

  2001cited by this paper
• Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.

  2001cited by this paper
• DAB(389)IL-2 (denileukin diftitox, ONTAK): other potential applications.

  2000cited by this paper
• Resolution of cutaneous inflammation after local elimination of macrophages

  2000cited by this paper
• Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity.

  2000cited by this paper
• In vitro anti‐tumour activity of anti‐CD80 and anti‐CD86 immunotoxins containing type 1 ribosome‐inactivating proteins

  2000cited by this paper
• Growth regulation of skin fibroblasts.

  2000cited by this paper
• Dependence of Ricin Toxicity on Translocation of the Toxin A-chain from the Endoplasmic Reticulum to the Cytosol*

  1999cited by this paper
• Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.

  1998cited by this paper
• Immunotoxins for targeted cancer therapy.

  1998cited by this paper
• Membrane translocation of diphtheria toxin fragment A exploits early to late endosome trafficking machinery

  1997cited by this paper
• Fc receptors.

  1997cited by this paper
• An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

  1997cited by this paper
• Structural Bases of FcγR Functions

  1997cited by this paper
• Synthesis of green fluorescent protein-ricin and monitoring of its intracellular trafficking.

  1997cited by this paper
• Structural bases of Fc gamma R functions.

  1997cited by this paper
• Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxins

  1997cited by this paper
• Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice.

  1996cited by this paper
• Roles of Glu 349 and Asp 352 in membrane insertion and translocation by diphtheria toxin

  1996cited by this paper
• Cytotoxic effects of ricin without an interchain disulfide bond: genetic modification and chemical crosslinking studies.

  1995cited by this paper
• Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.

  1995cited by this paper
• Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver.

  1994cited by this paper
• Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts.

  1994cited by this paper
• Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin

  1994cited by this paper
• Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.

  1993cited by this paper
• Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds.

  1993cited by this paper
• Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

  1992cited by this paper
• Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation

  1992cited by this paper
• A proper amino terminus of diphtheria toxin is important for cytotoxicity.

  1991cited by this paper
• Fc receptors.

  1991cited by this paper
• Biology of Human Immunoglobulin G Fc Receptors

  1991cited by this paper
• Epidermal cytokines and their roles in cutaneous wound healing

  1991cited by this paper
• Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.

  1990cited by this paper
• High-pressure-liquid-chromatographic and fluorimetric methods for the determination of adenine released from ribosomes by ricin and gelonin.

  1989cited by this paper
• Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.

  1989cited by this paper

• Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b^+CD64^+ patients with acute myeloid leukemia

  2023cites this paper
• The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer

  2022cites this paper
• Role of prostaglandin E2 in macrophage polarization: insights into atherosclerosis.

  2022cites this paper
• PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion

  2021cites this paper
• A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages

  2020cites this paper
• Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases

  2020cites this paper
• Macrophages skew towards M1 profile through reduced CD163 expression in symptomatic apical periodontitis

  2020cites this paper
• Functional aspects, phenotypic heterogeneity, and tissue immune response of macrophages in infectious diseases

  2019cites this paper
• Polymeric Nanomaterials

  2019cites this paper
• Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.

  2019cites this paper
• Precision nanomedicine in atherosclerosis therapy: how far are we from reality?

  2019cites this paper
• Cordycepin Attenuates IFN-γ-Induced Macrophage IP-10 and Mig Expressions by Inhibiting STAT1 Activity in CFA-Induced Inflammation Mice Model

  2019cites this paper
• Organization of the Skin Immune System and Compartmentalized Immune Responses in Infectious Diseases

  2019cites this paper
• Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity

  2018cites this paper
• Response of Cellular Innate Immunity to Cnidarian Pore-Forming Toxins

  2018cites this paper
• Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis

  2018cites this paper
• Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins

  2018cites this paper
• Regulation of iNOS on Immune Cells and Its Role in Diseases

  2018cites this paper
• Fc&ggr;RI (CD64) contributes to the severity of immune inflammation through regulating NF‐&kgr;B/NLRP3 inflammasome pathway

  2018cites this paper
• Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

  2017cites this paper
• Recombinant Immunotoxins for Chronic Inflammatory Disease

  2017cites this paper
• CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases

  2017cites this paper
• Comparative analysis of the internalization of the macrophage receptor sialoadhesin in human and mouse primary macrophages and cell lines.

  2017cites this paper
• Fully human MAP‐fusion protein selectively targets and eliminates proliferating CD64+ M1 macrophages

  2016cites this paper
• Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.

  2016influential citation
• Dexamethasone phosphate-loaded folate-conjugated polymeric nanoparticles for selective delivery to activated macrophages and suppression of inflammatory responses

  2015cites this paper
• Specifically targeted delivery of protein to phagocytic macrophages

  2015cites this paper
• Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization

  2015cites this paper
• The role of physiological elements in the future therapies of rheumatoid arthritis. II. The relevance of energy redistribution in the process of chronic inflammation*

  2015cites this paper
• Neisseria gonorrhoeae Modulates Immunity by Polarizing Human Macrophages to a M2 Profile

  2015influential citation
• Chronic rhinosinusitis and cystic fibrosis: the interaction between sinus bacteria and mucosal immunity

  2015cites this paper
• The many faces of FcγRI: implications for therapeutic antibody function

  2015cites this paper
• Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies

  2015cites this paper
• The Fc‐alpha receptor is a new target antigen for immunotherapy of myeloid leukemia

  2015cites this paper
• Apigenin Induces the Apoptosis and Regulates MAPK Signaling Pathways in Mouse Macrophage ANA-1 Cells

  2014cites this paper
• CD64-mediated specific elimination of M1-polarized macrophages : implications for therapeutic intervention in chronic inflammatory diseases

  2013cites this paper
• The interaction between bacteria and mucosal immunity in chronic rhinosinusitis: a prospective cross-sectional analysis.

  2013cites this paper
• Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells.

  2013cites this paper
• Composé modifiant les microtubules

  2013cites this paper
• Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22 (scFv) and H22

  2013cites this paper
• Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo

  2013cites this paper
• The Interaction between Bacteria and Mucosal Immunity in Chronic Rhinosinusitis: A Prospective Cross-sectional Analysis

  2013cites this paper